Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01994395 · ClinicalTrials.gov registry record · NA
Development of Walk Assist Device to Improve Community Ambulation
A NA study, sponsored by Shirley Ryan AbilityLab.
- Completed
- Registry status
- NA
- Development phase
- 53
- Enrollment target
NCT01994395 is a NA study that has completed, run by Shirley Ryan AbilityLab. The registered enrollment target is 53 participants.
The verdict
NCT01994395, a NA study, has completed, sponsored by Shirley Ryan AbilityLab.
- COMPLETED
- Registry status
- NA
- Development phase
- 53 participants
- Enrollment target
Study Summary
Hypothesis/Specific Aims: The purpose of this study is to determine the effect of training with the Stride Management Assist (SMA) device vs. Impairment based physical therapy (IPT) on descending corticospinal drive to the lower limb muscles in patients post stroke. The investigators hypothesize that long-term SMA use would strengthen the connections between the motor areas of the brain and the lower limbs. Specifically, individuals in the SMA group will show higher corticospinal excitability of the lower limb muscles compared to those in the IPT group.
Interventions
- DEVICE The Stride Management Assist (SMA) System
- OTHER Impairment based therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2013-10 |
| Est. Completion | 2020-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01994395
The ClinicalTrials.gov registry entry for NCT01994395 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Shirley Ryan AbilityLab, which has 138 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which The Stride Management Assist (SMA) System is the first listed.
NCT01994395 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01994395 about?
NCT01994395 is a clinical study titled "Development of Walk Assist Device to Improve Community Ambulation". Hypothesis/Specific Aims: The purpose of this study is to determine the effect of training with the Stride Management Assist (SMA) device vs. Impairment based physical therapy (IPT) on descending corticospinal drive to the lower limb muscles in patients post stroke. The investigators hypothesize th...
What is the current status of trial NCT01994395?
This trial is currently completed. It is a NA study. The enrollment target is 53 participants. The study started on 2013-10. Estimated completion is 2020-02.
What interventions are being tested in trial NCT01994395?
The interventions under investigation include: The Stride Management Assist (SMA) System (DEVICE), Impairment based therapy (OTHER).
Who is sponsoring clinical trial NCT01994395?
This trial is sponsored by Shirley Ryan AbilityLab, which has 138 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.